Skip to main content

Nymox Pharmaceutical Corp

NYMXF
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001018735

No open-market purchases or sales by Nymox Pharmaceutical Corp insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.21K in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Nymox Pharmaceutical Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
35
0 vs. Q4 2022
Shares held
1.69M
+341.7K (+25.4%) vs. Q4 2022
Total value
$575.1K
+$149.4K (+35.1%) vs. Q4 2022
New holders
5
7 more added
Sold out
5
8 more reduced

2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NYMXF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 35 institutions
Q1 2021: 59 institutionsQ2 2021: 51 institutionsQ3 2021: 38 institutionsQ4 2021: 43 institutionsQ1 2022: 40 institutionsQ2 2022: 39 institutionsQ3 2022: 34 institutionsQ4 2022: 37 institutionsQ1 2023: 35 institutionsQ2 2023: 36 institutionsQ3 2023: 5 institutionsQ4 2023: 2 institutionsQ1 2024: 3 institutionsQ2 2024: 1 institutionQ3 2024: 2 institutionsQ4 2024: 1 institutionQ1 2025: 2 institutionsQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ1 2023: $575.1K
Q1 2021: $13.4MQ2 2021: $4.03MQ3 2021: $4.00MQ4 2021: $2.05MQ1 2022: $2.25MQ2 2022: $590.1KQ3 2022: $494.6KQ4 2022: $443.7KQ1 2023: $575.1KQ2 2023: $287.4KQ3 2023: $68.3KQ4 2023: $26.6KQ1 2024: $48.0KQ2 2024: $6.67KQ3 2024: $13.2KQ4 2024: $3.51KQ1 2025: $16.0KQ2 2025: $4.13KQ3 2025: $2.06KQ4 2025: $1.41KQ1 2026: $2.46KQ2 2026: $4.21K
Institutions holding NYMXF and their total value by quarter
QuarterHoldersValue
Q2 20261$4.21K
Q1 20261$2.46K
Q4 20251$1.41K
Q3 20251$2.06K
Q2 20251$4.13K
Q1 20252$16.0K
Q4 20241$3.51K
Q3 20242$13.2K
Q2 20241$6.67K
Q1 20243$48.0K
Q4 20232$26.6K
Q3 20235$68.3K
Q2 202336$287.4K
Q1 202335$575.1K
Q4 202237$443.7K
Q3 202234$494.6K
Q2 202239$590.1K
Q1 202240$2.25M
Q4 202143$2.05M
Q3 202138$4.00M
Q2 202151$4.03M
Q1 202159$13.4M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Nymox Pharmaceutical Corp; share changes are against Q4 2022.

Institutions holding NYMXF in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Federation des caisses Desjardins du Quebec351,000$119.3K0.00%−29,800−7.8%Reduced
Corrigan Financial, Inc.302,252$102.8K0.03%+302,252New
BlackRock Inc.135,612$46.1K0.00%+3,918+3.0%Added
Cetera Advisor Networks LLC118,900$40.4K0.00%+51,775+77.1%Added
Morgan Stanley98,686$33.6K0.00%+1,068+1.1%Added
Bleakley Financial Group, LLC80,000$27.2K0.00%00.0%Unchanged
Sawtooth Solutions, LLC80,000$27.2K0.00%+80,000New
Renaissance Technologies LLC69,381$24.0K0.00%−13,419−16.2%Reduced
Citadel Advisors LLC60,306$20.5K0.00%−23,858−28.3%Reduced
Geode Capital Management, LLC50,678$17.2K0.00%00.0%Unchanged
Millennium Management LLC47,916$16.0K0.00%+47,916New
Susquehanna International Group, LLP39,621$13.5K0.00%−10,077−20.3%Reduced
Brown Advisory Inc28,000$9.52K0.00%00.0%Unchanged
CI Private Wealth, LLC25,000$8.50K0.00%00.0%Unchanged
Beaird Harris Wealth Management, LLC24,400$8.30K0.00%00.0%Unchanged
Two Sigma Securities, LLC21,322$7.25K0.00%+1,250+6.2%Added
Advisor Group Holdings, Inc.20,400$6.94K0.00%00.0%Unchanged
Goldman Sachs Group Inc19,984$6.79K0.00%00.0%Unchanged
WMS Partners, LLC18,000$6.12K0.00%00.0%Unchanged
National Bank of Canada17,200$5.85K0.00%00.0%Unchanged
Virtu Financial LLC13,324$5.00K0.00%−6,322−32.2%Reduced
Kestra Advisory Services, LLC11,532$3.92K0.00%00.0%Unchanged
Cubic Asset Management, LLC10,000$3.40K0.00%−4,000−28.6%Reduced
Great Valley Advisor Group, Inc.10,000$3.40K0.00%00.0%Unchanged
One Day In July LLC10,000$3.40K0.00%00.0%Unchanged
JPMorgan Chase & Co7,744$3.00K0.00%−1,611−17.2%Reduced
Group One Trading, L.P.5,240$1.78K0.00%+300+6.1%Added
BDO Wealth Advisors, LLC4,700$1.60K0.00%00.0%Unchanged
Wells Fargo & Company3,296$1.12K0.00%+200+6.5%Added
Belpointe Asset Management LLC2,221$7550.00%+2,221New
BNP Paribas Arbitrage, SA859$2920.00%−344−28.6%Reduced
Bank of America Corp708$2400.00%+354+100.0%Added
UBS Group AG375$1280.00%00.0%Unchanged
Steward Financial Group LLC100$00.00%00.0%Unchanged
Tower Research Capital LLC (TRC)636$00.00%+636New
Jane Street Group, LLC0$00.00%−25,126−100.0%Sold out
Patriot Financial Group Insurance Agency, LLC0$00.00%−19,900−100.0%Sold out
Credit Suisse AG0$00.00%−7,490−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−7,000−100.0%Sold out
PSI Advisors, LLC0$00.00%−1,200−100.0%Sold out
First Citizens Financial Corp––––Not filed
Gofen & Glossberg LLC––––Not filed